Inventor · disambiguated record
Susan D. Croll
Also filed as: CROLL SUSAN · CROLL SUSAN D
12 granted patents·6 pending applications·21 citations·filing 2013–2024
86Inventor score
Files withREGENERON PHARMA18
Top patents by PatentIndex Score
18 records- 0191US11926661B2Human antibodies to artemin and methods of use thereofREGENERON PHARMA·Filed 2022·Granted Mar 12, 2024·1 cites·27 claims
- 0291US9522185B2Human antibodies to GFR α3 and methods of treating pain associated with osteoarthritis or bone cancerREGENERON PHARMA·Filed 2014·Granted Dec 20, 2016·5 cites·9 claims
- 0390US8968736B2Human antibodies to GFRα3 and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Mar 3, 2015·11 cites·6 claims
- 0482US10077311B2Human antibodies to GFR alpha3 and methods of reducing pain associated with GFR alpha3-related diseasesREGENERON PHARMA·Filed 2016·Granted Sep 18, 2018·2 cites·10 claims
- 0581US12441784B2Human antibodies to artemin and methods of use thereofREGENERON PHARMA·Filed 2024·Granted Oct 14, 2025·0 cites·47 claims
- 0681US2024309100A1Anti-Trkb Monoclonal Antibodies And Methods Of UseREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0780US11470828B2Rodent model of mood disordersREGENERON PHARMA·Filed 2020·Granted Oct 18, 2022·1 cites·24 claims
- 0876US11419318B2Genetically modified rat comprising a humanized TRKB locusREGENERON PHARMA·Filed 2018·Granted Aug 23, 2022·1 cites·9 claims
- 0976US10947312B2Human antibodies to GFRα3 and methods of making thereofREGENERON PHARMA·Filed 2019·Granted Mar 16, 2021·0 cites·24 claims
- 1072US12037401B2Anti-TrkB monoclonal antibodies and methods of useREGENERON PHARMA·Filed 2021·Granted Jul 16, 2024·0 cites·12 claims
- 1171US12396444B2Mouse comprising a humanized TRKB locusREGENERON PHARMA·Filed 2022·Granted Aug 26, 2025·0 cites·14 claims
- 1271US2018340029A1Human antibodies to gfr alpha 3 and methods of use thereofREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 1370US11066474B2Anti-TrkB monoclonal antibodies and methods of useREGENERON PHARMA·Filed 2018·Granted Jul 20, 2021·0 cites·9 claims
- 1470US2023123787A1Rodent model of mood disordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1569US2021392865A1Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perceptionREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1663US2019261610A1Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perceptionREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 1755US10285387B2Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perceptionREGENERON PHARMA·Filed 2016·Granted May 14, 2019·0 cites·21 claims
- 1844US2016120941A1Methods of using il-1 antagonists to treat alzheimer's diseaseREGENERON PHARMA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susan D. Croll files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →